Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Genetics, environment, and diabetes-related end-stage renal disease in the Canary Islands.

González AM, Maceira BM, Pérez E, Cabrera VM, López AJ, Larruga JM.

Genet Test Mol Biomarkers. 2012 Aug;16(8):859-64. doi: 10.1089/gtmb.2011.0207. Epub 2012 Apr 5.

2.

Disproportionately high incidence of diabetes-related end-stage renal disease in the Canary Islands. An analysis based on estimated population at risk.

Lorenzo V, Boronat M, Saavedra P, Rufino M, Maceira B, Novoa FJ, Torres A.

Nephrol Dial Transplant. 2010 Jul;25(7):2283-8. doi: 10.1093/ndt/gfp761. Epub 2010 Jan 11.

PMID:
20064954
3.

Demographic history of Canary Islands male gene-pool: replacement of native lineages by European.

Fregel R, Gomes V, Gusmão L, González AM, Cabrera VM, Amorim A, Larruga JM.

BMC Evol Biol. 2009 Aug 3;9:181. doi: 10.1186/1471-2148-9-181.

4.

High-density single nucleotide polymorphism genome-wide linkage scan for susceptibility genes for diabetic nephropathy in type 1 diabetes: discordant sibpair approach.

Rogus JJ, Poznik GD, Pezzolesi MG, Smiles AM, Dunn J, Walker W, Wanic K, Moczulski D, Canani L, Araki S, Makita Y, Warram JH, Krolewski AS.

Diabetes. 2008 Sep;57(9):2519-26. doi: 10.2337/db07-1086. Epub 2008 Jun 16.

5.

Isolation and prominent aboriginal maternal legacy in the present-day population of La Gomera (Canary Islands).

Fregel R, Cabrera VM, Larruga JM, Hernández JC, Gámez A, Pestano JJ, Arnay M, González AM.

Eur J Hum Genet. 2015 Sep;23(9):1236-43. doi: 10.1038/ejhg.2014.251. Epub 2014 Nov 19.

6.

Genome-wide SNP genotyping study using pooled DNA to identify candidate markers mediating susceptibility to end-stage renal disease attributed to Type 1 diabetes.

Craig DW, Millis MP, DiStefano JK.

Diabet Med. 2009 Nov;26(11):1090-8. doi: 10.1111/j.1464-5491.2009.02846.x.

PMID:
19929986
7.

Coding variants in nephrin (NPHS1) and susceptibility to nephropathy in African Americans.

Bonomo JA, Ng MC, Palmer ND, Keaton JM, Larsen CP, Hicks PJ; T2D-GENES Consortium, Langefeld CD, Freedman BI, Bowden DW.

Clin J Am Soc Nephrol. 2014 Aug 7;9(8):1434-40. doi: 10.2215/CJN.00290114. Epub 2014 Jun 19.

8.

[Current peritoneal dialysis compared with haemodialysis: medium-term survival analysis of incident dialysis patients in the Canary Islands in recent years].

Rufino JM, García C, Vega N, Macía M, Hernández D, Rodríguez A, Maceira B, Lorenzo V.

Nefrologia. 2011;31(2):174-84. doi: 10.3265/Nefrologia.pre2011.Jan.10743. Spanish.

9.

Genetic analysis of nitric oxide and endothelin in end-stage renal disease.

Freedman BI, Yu H, Anderson PJ, Roh BH, Rich SS, Bowden DW.

Nephrol Dial Transplant. 2000 Nov;15(11):1794-800.

PMID:
11071967
10.

Genetic determinants of albuminuria and renal disease in diabetes mellitus.

Sale MM, Freedman BI.

Nephrol Dial Transplant. 2006 Jan;21(1):13-6. Epub 2005 Oct 18. Review. No abstract available.

PMID:
16234290
11.

Predisposition to nephropathy in Polynesians is associated with family history of renal disease, not diabetes mellitus.

Thompson CF, Simmons D, Collins JF, Cecil A.

Diabet Med. 2001 Jan;18(1):40-6.

PMID:
11168340
12.

Genetic association studies in diabetic nephropathy.

Gu HF, Brismar K.

Curr Diabetes Rev. 2012 Sep;8(5):336-44. Review.

PMID:
22587511
13.

Association of mitochondrial DNA haplogroups and vascular complications of diabetes mellitus: A population-based study.

Martikainen MH, Rönnemaa T, Majamaa K.

Diab Vasc Dis Res. 2015 Jul;12(4):302-4. doi: 10.1177/1479164115579007. Epub 2015 Apr 28.

PMID:
25920916
14.

Linkage analysis of candidate loci for end-stage renal disease due to diabetic nephropathy.

Iyengar SK, Fox KA, Schachere M, Manzoor F, Slaughter ME, Covic AM, Orloff SM, Hayden PS, Olson JM, Schelling JR, Sedor JR.

J Am Soc Nephrol. 2003 Jul;14(7 Suppl 2):S195-201.

15.

CD2AP is associated with end-stage renal disease in patients with type 1 diabetes.

Hyvönen ME, Ihalmo P, Sandholm N, Stavarachi M, Forsblom C, McKnight AJ, Lajer M, Maestroni A, Lewis G, Tarnow L, Maestroni S, Zerbini G, Parving HH, Maxwell AP, Groop PH, Lehtonen S.

Acta Diabetol. 2013 Dec;50(6):887-97. doi: 10.1007/s00592-013-0475-9. Epub 2013 May 17.

PMID:
23681557
16.

Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes.

Cowie CC, Port FK, Wolfe RA, Savage PJ, Moll PP, Hawthorne VM.

N Engl J Med. 1989 Oct 19;321(16):1074-9.

PMID:
2797067
17.

A family-based strategy to identify genes for diabetic nephropathy.

Covic AM, Iyengar SK, Olson JM, Sehgal AR, Constantiner M, Jedrey C, Kara M, Sabbagh E, Sedor JR, Schelling JR.

Am J Kidney Dis. 2001 Mar;37(3):638-47.

PMID:
11228193
18.

Genetic initiation of hypertensive and diabetic nephropathy.

Freedman BI, Bowden DW, Rich SS, Appel RG.

Am J Hypertens. 1998 Feb;11(2):251-7. Review.

PMID:
9524057
19.

Diabetic renal disease: racial and ethnic differences from an epidemiologic perspective.

Cowie CC.

Transplant Proc. 1993 Aug;25(4):2426-30. Review.

PMID:
8356621
20.

Serum C-peptide concentrations poorly phenotype type 2 diabetic end-stage renal disease patients.

Covic AM, Schelling JR, Constantiner M, Iyengar SK, Sedor JR.

Kidney Int. 2000 Oct;58(4):1742-50.

Supplemental Content

Support Center